Is Prevest Denpro overvalued or undervalued?
2025-12-04 08:45:51Valuation Metrics and Financial Health Prevest Denpro’s price-to-earnings (PE) ratio stands at approximately 27.3, which is elevated compared to many industry peers but not excessively high for a growth-oriented healthcare company. The price-to-book (P/B) ratio of 4.63 indicates that investors are paying a significant premium over the company’s net asset value, reflecting expectations of strong future earnings growth. Enterprise value to EBITDA (EV/EBITDA) at 19.4 and EV to EBIT at 21.2 further suggest that the market values the company’s operating profits highly. These multiples are lower than some very expensive peers but still indicate a premium valuation. Importantly, Prevest Denpro’s return on capital employed (ROCE) is an impressive 52.16%, signalling high...
Read More
Prevest Denpro Sees Revision in Market Evaluation Amidst Challenging Performance
2025-12-01 10:09:16Prevest Denpro, a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. The company’s assessment metrics have been adjusted following a period marked by subdued financial trends and valuation concerns, signalling a cautious stance among investors.
Read MoreWhy is Prevest Denpro falling/rising?
2025-11-25 01:44:05Recent Price Movement and Market Context Prevest Denpro’s stock has been on a downward spiral, losing 8.48% over the past week compared to a near-flat Sensex performance of -0.06%. The one-month decline is even more pronounced at -18.68%, while the Sensex has gained 0.82% in the same period. Year-to-date, the stock has fallen 27.14%, starkly contrasting with the Sensex’s 8.65% rise. Over the last year, Prevest Denpro has delivered a negative return of 20.39%, whereas the benchmark index has appreciated by 7.31%. Even over a three-year horizon, the stock’s 9.85% gain pales in comparison to the Sensex’s robust 36.34% advance. On 24-Nov, the stock opened with a gap down of 2.21% and continued to weaken, hitting an intraday low of ₹429.90, marking a 6.58% drop on the day. ...
Read MoreWhy is Prevest Denpro falling/rising?
2025-11-20 00:07:05As of 19-Nov, Prevest Denpro Ltd's stock price is currently at 465.00, reflecting a decrease of 3.95, or 0.84%. The stock has been underperforming, having lost 5.25% over the past week and 10.40% over the past month. It has also experienced a consecutive decline for the last five days. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a slight increase in delivery volume by 13.3% against the 5-day average, the overall performance today has underperformed the sector by 0.74%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Prevest Denpro's performance has significantly lagged behind the Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Year-to-date, the stock has declined by 21.19%...
Read More
Prevest Denpro Q2 FY26: Strong Quarter Overshadowed by Valuation Concerns
2025-11-14 09:44:16Prevest Denpro Limited, one of India's leading dental materials manufacturers, reported a robust second quarter for FY2026, with net profit climbing 25.62% quarter-on-quarter to ₹5.54 crores. However, the micro-cap company's stock has tumbled 11.31% over the past year, trading at ₹478.90 as of November 14, 2025, with a market capitalisation of ₹574.82 crores. Despite solid operational performance and industry-leading profitability metrics, the stock faces mounting pressure from stretched valuations and deteriorating technical momentum.
Read MoreHow has been the historical performance of Prevest Denpro?
2025-11-13 23:48:12Answer: The historical performance of Prevest Denpro shows a positive trend in key financial metrics from March 2024 to March 2025. Breakdown: In the fiscal year ending March 2025, Prevest Denpro reported net sales of 63.03 Cr, an increase from 56.43 Cr in the previous year. The total operating income also rose to 63.03 Cr from 56.43 Cr, with raw material costs slightly increasing to 14.08 Cr from 13.76 Cr. Total expenditure, excluding depreciation, grew to 40.94 Cr from 36.58 Cr, leading to an operating profit (PBDIT) of 26.16 Cr, up from 22.71 Cr. Profit before tax increased to 24.25 Cr from 21.43 Cr, resulting in a profit after tax of 18.16 Cr, compared to 16.14 Cr the previous year. The earnings per share improved to 15.13 from 13.45, while the operating profit margin slightly decreased to 35.05% from 35.18%. The profit after tax margin increased to 28.81% from 28.6%. On the balance sheet, shareholder'...
Read MoreHow has been the historical performance of Prevest Denpro?
2025-11-13 00:36:07Answer: The historical performance of Prevest Denpro shows significant growth from March 2024 to March 2025. Breakdown: In the fiscal year ending March 2025, Prevest Denpro reported net sales of 63.03 Cr, an increase from 56.43 Cr in the previous year. Total operating income also rose to 63.03 Cr from 56.43 Cr, while total expenditure increased to 40.94 Cr from 36.58 Cr. The operating profit (PBDIT) excluding other income improved to 22.09 Cr compared to 19.85 Cr, leading to an overall operating profit of 26.16 Cr, up from 22.71 Cr. Profit before tax increased to 24.25 Cr from 21.43 Cr, resulting in a profit after tax of 18.16 Cr, which is higher than the 16.14 Cr reported in the prior year. The earnings per share also grew from 13.45 to 15.13. On the balance sheet, shareholder's funds rose to 105.57 Cr from 88.62 Cr, and total assets increased to 112.53 Cr from 94.82 Cr. The company maintained zero long-t...
Read MoreWhy is Prevest Denpro falling/rising?
2025-11-11 00:02:43As of 10-Nov, Prevest Denpro Ltd's stock price is currently at Rs 490.00, reflecting a decline of Rs 20.0 or 3.92%. The stock has been underperforming, having lost 6.66% over the last three days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of returns, the stock has decreased by 5.77% over the past week and 9.01% over the past month, while it has experienced a significant drop of 16.95% year-to-date. Despite a low debt-to-equity ratio, the company has shown poor long-term growth, with net sales growing at an annual rate of only 13.42% and operating profit at 4.86% over the last five years. Additionally, the stock's valuation appears expensive with a price-to-book value of 5.6, and domestic mutual funds hold no stake in the company, indicating a lack of confidence in its current price. In the broader market context, the Sensex has shown a relatively stable pe...
Read MoreIs Prevest Denpro technically bullish or bearish?
2025-11-10 08:12:01As of 7 November 2025, the technical trend has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the weekly and monthly MACD and Dow Theory indicators, both indicating a bearish outlook. The Bollinger Bands also reflect a bearish sentiment on both weekly and monthly time frames. Although the daily moving averages show a mildly bullish signal, this is overshadowed by the overall bearish indicators. The stock has underperformed against the Sensex over multiple periods, further supporting the bearish view....
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14-Jan-2026 | Source : BSECertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
Closure of Trading Window
31-Dec-2025 | Source : BSEIntimation of Closure of Trading Window.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
24-Nov-2025 | Source : BSETranscipt of the Companys Earning call held on November 20 2025.
Corporate Actions
No Upcoming Board Meetings
Prevest Denpro Ltd has declared 10% dividend, ex-date: 03 Sep 25
No Splits history available
No Bonus history available
No Rights history available